An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $72.42M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 28.0¢ | $33.07K | 114.5K |
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 28.5¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 26762 | 1 |
| Last trade - 16.10pm 23/04/2025 (20 minute delay) ? |
| RCE (ASX) Chart |
